Involvement of the alpha3 subunit in central nicotinic binding populations
about
Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotypeA novel 4/7-conotoxin LvIA from Conus lividus that selectively blocks 3 2 vs. 6/ 3 2 3 nicotinic acetylcholine receptorsCholinergic left-right asymmetry in the habenulo-interpeduncular pathwayAlpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.Engineering neuronal nicotinic acetylcholine receptors with functional sensitivity to alpha-bungarotoxin: a novel alpha3-knock-in mouse.Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies.Alpha2 nicotine receptors function as a molecular switch to continuously excite a subset of interneurons in rat hippocampal circuits.A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction.An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutantsRecent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.Naturally-expressed nicotinic acetylcholine receptor subtypes.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.α6* nicotinic acetylcholine receptor expression and function in a visual salience circuit.Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice.Nicotinic receptors as CNS targets for Parkinson's diseaseThe subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholineGanglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompanimentsRodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine releaseCellular events in nicotine addiction.Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.Nicotinic receptor-based therapeutics and candidates for smoking cessation.Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.Pharmacological and immunochemical characterization of alpha2* nicotinic acetylcholine receptors (nAChRs) in mouse brain.The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse.QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes.Subunit composition of α5-containing nicotinic receptors in the rodent habenula.Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function.α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula.α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.
P2860
Q27021772-F49375B3-237F-4410-9EFD-4CC42A267CF4Q27681218-9FB74966-6C48-42A6-80F5-C3FB4F870CECQ30412360-9AF241F1-8AC3-499D-B599-CB3FEFF370C2Q30493138-24B93187-7D51-4A75-9D4C-7008F79FC509Q33636887-2AC11B93-0E48-4996-B127-EC3787ABAE83Q33954007-4BA9EF67-992A-49BD-A2CB-1945AAA70006Q34025082-CED0CDFD-67C6-4456-992B-6FF1807E3BFAQ34043452-FE43F421-3762-4836-8938-F3BB4086AD55Q34068084-5009EA51-703F-4A69-8ED4-5164E65A3ACEQ35181919-60B7DA28-FBFB-443F-9E40-5C8791A422C0Q35184641-B05B4684-A693-4387-84E3-12F220AF7606Q35185264-BA3A2DBD-6596-4066-8792-BDFB130CD12AQ35264378-B37E6AAC-B3D1-4E6E-AE3D-41EE099BF6DFQ36205910-37D10160-E542-479B-890B-5771D0CFD28AQ36304857-A3B7AD7A-3BE4-4B5F-8D3B-620347F735D5Q36517174-7889313D-CA88-4615-8E9F-9183CCFF4F75Q36672802-9C6E1C74-1B5E-47BD-8362-45F9D735DEA2Q36882136-47728555-EC98-4046-9D26-EF539B7A4B07Q36933882-C8231219-5FCB-4C05-B7BD-E984BD2A4346Q36960973-9105FA50-A3CE-427A-BC07-7E16C976E2DCQ37150553-88D83631-818F-4A3A-9CCF-A11025A96AF9Q37187599-281C561E-C862-4D73-A21E-707329DAD2E7Q37247103-5495653C-329B-42B2-896E-A3B250C9594FQ37473457-46384A49-7F8C-4E89-AFAA-D37C919F6624Q37508589-B700CCBB-8E52-42FF-8E01-504EDF183571Q37518024-518D53E9-E0ED-46C7-8068-2A2A9701E05AQ38204497-31BA7268-67A8-479D-B435-B5E9104DF35BQ39012456-0C24B80A-595B-448B-ACAA-80C788C010BAQ40392015-460C1FA3-3E92-4732-8631-548CB3622DB3Q41916671-CC301CD1-865D-4E6A-ABB3-588749FBABE3Q42131733-1D7209FD-6467-4D39-862B-E2A9FEC332FBQ42158126-1DB162EA-4513-458B-A718-8FC8EE4EDD04Q42565570-F3B4B42D-B1A7-4D7B-A827-857D15FAC703Q42728501-97CFCBB4-1019-459E-916A-FD7A6B6875BFQ42743728-CDBE673C-6A6E-4F64-9CD0-7BD2E3A3AE56Q43178185-1FD3B80F-659E-4E20-B67D-D0055CB0FD78Q47839971-9E111784-D31A-475C-BAAA-2D1AACDE51E1Q48531151-B19C6AA8-2C0F-4D35-970A-DEC3A8DDE4E0
P2860
Involvement of the alpha3 subunit in central nicotinic binding populations
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/04/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/04/01)
@nl
наукова стаття, опублікована у квітні 2002
@uk
مقالة علمية (نشرت في أبريل 2002)
@ar
name
Involvement of the alpha3 subunit in central nicotinic binding populations
@ast
Involvement of the alpha3 subunit in central nicotinic binding populations
@en
Involvement of the alpha3 subunit in central nicotinic binding populations
@nl
type
label
Involvement of the alpha3 subunit in central nicotinic binding populations
@ast
Involvement of the alpha3 subunit in central nicotinic binding populations
@en
Involvement of the alpha3 subunit in central nicotinic binding populations
@nl
prefLabel
Involvement of the alpha3 subunit in central nicotinic binding populations
@ast
Involvement of the alpha3 subunit in central nicotinic binding populations
@en
Involvement of the alpha3 subunit in central nicotinic binding populations
@nl
P2093
P1476
Involvement of the alpha3 subunit in central nicotinic binding populations
@en
P2093
Allan C Collins
Arthur L Beaudet
Cyrus G Peterson
J Michael McIntosh
Michael J Marks
Paul Whiteaker
Richard Paylor
P304
P356
10.1523/JNEUROSCI.22-07-02522.2002
P407
P577
2002-04-01T00:00:00Z